SYNLOGIC, INC. Investing Cash Flow
SYNLOGIC, INC. (SYBX) reported Investing Cash Flow of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-11
- SYNLOGIC, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. net cash provided by (used in) investing activities for fiscal 2025 was $167.00K, a 99.34% decline from fiscal 2024.
- SYNLOGIC, INC. net cash provided by (used in) investing activities for fiscal 2024 was $25.34M, a 34.64% decline from fiscal 2023.
- SYNLOGIC, INC. net cash provided by (used in) investing activities for fiscal 2023 was $38.77M, a 33.56% decline from fiscal 2022.
- SYNLOGIC, INC. net cash provided by (used in) investing activities for fiscal 2022 was $58.35M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $0.00 10-Q · filed 2026-08-11 | $0.00 derived: sum of 3 quarters · filed 2026-08-11 | $0.00 derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-14 | $0.00 derived: sum of 2 quarters · filed 2026-05-14 | $0.00 derived: sum of 3 quarters · filed 2026-05-14 | $155.00K derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $155.00K derived: sum of 3 quarters · filed 2026-08-11 | $167.00K 10-K · filed 2026-03-12 | ||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $155.00K derived: sum of 2 quarters · filed 2026-08-11 | $167.00K 10-Q · filed 2025-11-13 | $197.00K derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | $155.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $167.00K 10-Q · filed 2026-08-11 | $197.00K derived: sum of 3 quarters · filed 2026-08-11 | $269.00K derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-03-31 | $12.00K 10-Q · filed 2026-05-14 | $42.00K derived: sum of 2 quarters · filed 2026-05-14 | $114.00K derived: sum of 3 quarters · filed 2026-05-14 | $9.07M derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $102.00K derived: sum of 2 quarters · filed 2026-03-12 | $9.06M derived: sum of 3 quarters · filed 2026-03-12 | $25.34M 10-K · filed 2026-03-12 | ||
| 2024-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $9.03M derived: sum of 2 quarters · filed 2025-11-13 | $25.31M 10-Q · filed 2025-11-13 | $10.68M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $8.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $25.24M 10-Q · filed 2025-08-07 | $10.61M derived: sum of 3 quarters · filed 2025-08-07 | $1.78M derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | $16.28M 10-Q · filed 2025-05-08 | $1.65M derived: sum of 2 quarters · filed 2025-05-08 | -$7.18M derived: sum of 3 quarters · filed 2025-05-08 | $24.78M derived: sum of 4 quarters · filed 2025-05-08 | ||
| 2023-12-31 | -$14.63M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$23.46M derived: sum of 2 quarters · filed 2025-03-06 | $8.50M derived: sum of 3 quarters · filed 2025-03-06 | $38.77M 10-K · filed 2025-03-06 | ||
| 2023-09-30 | -$8.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $23.13M derived: sum of 2 quarters · filed 2024-11-12 | $53.40M 10-Q · filed 2024-11-12 | $68.26M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $31.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $62.23M 10-Q · filed 2024-08-08 | $77.09M derived: sum of 3 quarters · filed 2024-08-08 | $77.21M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $30.27M 10-Q · filed 2024-05-14 | $45.13M derived: sum of 2 quarters · filed 2024-05-14 | $45.25M derived: sum of 3 quarters · filed 2024-05-14 | $68.86M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $14.86M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $14.98M derived: sum of 2 quarters · filed 2024-03-19 | $38.59M derived: sum of 3 quarters · filed 2024-03-19 | $58.35M 10-K · filed 2024-03-19 | ||
| 2022-09-30 | $119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $23.73M derived: sum of 2 quarters · filed 2023-11-09 | $43.49M 10-Q · filed 2023-11-09 | $10.18M derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $23.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $43.37M 10-Q · filed 2023-08-10 | $10.06M derived: sum of 3 quarters · filed 2023-08-10 | $8.71M derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $19.76M 10-Q · filed 2023-05-11 | -$13.55M derived: sum of 2 quarters · filed 2023-05-11 | -$14.90M derived: sum of 3 quarters · filed 2023-05-11 | -$33.65M derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$33.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$34.66M derived: sum of 2 quarters · filed 2023-03-29 | -$53.41M derived: sum of 3 quarters · filed 2023-03-29 | -$53.25M 10-K · filed 2023-03-29 | ||
| 2021-09-30 | -$1.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$20.10M derived: sum of 2 quarters · filed 2022-11-10 | -$19.95M 10-Q · filed 2022-11-10 | -$12.84M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | -$18.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$18.59M 10-Q · filed 2022-08-11 | -$11.48M derived: sum of 3 quarters · filed 2022-08-11 | -$9.02M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $154.00K 10-Q · filed 2022-05-12 | $7.26M derived: sum of 2 quarters · filed 2022-05-12 | $9.72M derived: sum of 3 quarters · filed 2022-05-12 | $26.82M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $7.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $9.57M derived: sum of 2 quarters · filed 2022-03-17 | $26.66M derived: sum of 3 quarters · filed 2022-03-17 | $32.48M 10-K · filed 2022-03-17 | ||
| 2020-09-30 | $2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $19.56M derived: sum of 2 quarters · filed 2021-11-10 | $25.37M 10-Q · filed 2021-11-10 | $35.38M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $17.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $22.91M 10-Q · filed 2021-08-12 | $32.92M derived: sum of 3 quarters · filed 2021-08-12 | $53.54M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $5.82M 10-Q · filed 2021-05-13 | $15.83M derived: sum of 2 quarters · filed 2021-05-13 | $36.45M derived: sum of 3 quarters · filed 2021-05-13 | -$1.06M derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $10.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $30.63M derived: sum of 2 quarters · filed 2021-03-25 | -$6.88M derived: sum of 3 quarters · filed 2021-03-25 | $10.80M 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $20.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$16.89M derived: sum of 2 quarters · filed 2020-11-05 | $787.00K 10-Q · filed 2020-11-05 | $3.70M derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | -$37.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$19.83M 10-Q · filed 2020-08-06 | -$16.91M derived: sum of 3 quarters · filed 2020-08-06 | -$16.61M derived: sum of 4 quarters · filed 2020-08-06 | ||
| 2019-03-31 | $17.68M 10-Q · filed 2020-05-08 | $20.59M derived: sum of 2 quarters · filed 2020-05-08 | $20.90M derived: sum of 3 quarters · filed 2020-05-08 | $2.34M derived: sum of 4 quarters · filed 2020-05-08 | ||
| 2018-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $3.23M derived: sum of 2 quarters · filed 2020-03-12 | -$15.33M derived: sum of 3 quarters · filed 2020-03-12 | -$87.20M 10-K · filed 2020-03-12 | ||
| 2018-09-30 | $309.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$18.25M derived: sum of 2 quarters · filed 2019-11-12 | -$90.12M 10-Q · filed 2019-11-12 | -$101.61M derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | -$18.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$90.43M 10-Q · filed 2019-08-08 | -$101.91M derived: sum of 3 quarters · filed 2019-08-08 | -$80.73M derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | -$71.87M 10-Q · filed 2019-05-09 | -$83.36M derived: sum of 2 quarters · filed 2019-05-09 | -$62.17M derived: sum of 3 quarters · filed 2019-05-09 | -$66.47M derived: sum of 4 quarters · filed 2019-05-09 | ||
| 2017-12-31 | -$11.49M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $9.70M derived: sum of 2 quarters · filed 2019-03-12 | $5.40M derived: sum of 3 quarters · filed 2019-03-12 | $9.28M 10-K · filed 2019-03-12 | ||
| 2017-09-30 | $21.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $16.89M derived: sum of 2 quarters · filed 2018-11-13 | $20.77M 10-Q · filed 2018-11-13 | $19.72M 10-Q · filed 2017-11-13 | ||
| 2017-06-30 | -$4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$419.00K 10-Q · filed 2018-08-09 | $14.18M 10-Q · filed 2017-08-04 | |||
| 2017-03-31 | $3.88M 10-Q · filed 2017-05-09 | |||||
| 2016-09-30 | $43.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $26.13M derived: sum of 2 quarters · filed 2017-11-13 | -$1.74M 10-Q · filed 2017-11-13 | |||
| 2016-06-30 | -$16.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$44.83M 10-Q · filed 2017-08-04 | ||||
| 2016-03-31 | -$27.86M 10-Q · filed 2017-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |